Skip to content
    HQY
    Earnings call· Apr 2026(Q1 FY27)

    HEALTHEQUITY Q1 FY27 earnings call HQY

    May 28, 2026 Source

    Executive summary

    HealthEquity Q1 FY27 — Strong Profitability and Raised FY27 Guidance

    HealthEquity delivered strong Q1 FY27 results, driven by disciplined execution, expanding adjusted EBITDA margins, and accelerating growth in HSA accounts and assets. The company raised its full-year guidance, reflecting confidence in its financial model and strategic initiatives, including significant investments in AI and an expanded share repurchase program. This quarter highlights HealthEquity's evolution towards a comprehensive healthcare financial operating system, enhancing member engagement and operational efficiency.

    Highlights

    6

    • Adjusted EBITDA margin expanded to 46% in Q1 FY27, up from 42% in Q1 FY26.

    • Total HSA assets grew 19% year-over-year.

    • New HSAs from sales grew 15%, adding 172,000 new HSAs to the platform.

    • HSA investors grew 18% and invested assets held by HSA members grew 38%.

    • Share repurchase authorization increased by $1 billion, reflecting confidence in long-term outlook.

    • AI-driven tools reduced manual handling of service emails by 25% and fraud costs declined nearly 90% year-over-year.

    Concerns

    2

    • Lower-than-expected medical claim usage utilization for internal employees impacted service costs by approximately $2 million, considered seasonal.

    • Interchange revenue grew 5% year-over-year, a slower pace potentially reflecting lower healthcare utilization.

    Guidance & targets

    8
    CategoryTargetConfidence
    Fiscal 2027 Revenue
    $1.41 billion to $1.42 billion
    high materiality
    High
    Fiscal 2027 GAAP Net Income
    $242 million to $248 million
    high materiality
    High
    Fiscal 2027 GAAP Diluted EPS
    $2.88 to $2.95 per share
    high materiality
    High
    Fiscal 2027 Non-GAAP Net Income
    $392 million to $398 million
    high materiality
    High
    Fiscal 2027 Non-GAAP Diluted EPS
    $4.66 and $4.73 per share
    high materiality
    High
    Fiscal 2027 Adjusted EBITDA
    $625 million and $633 million
    high materiality
    High
    Fiscal 2027 Average Yield on HSA Cash
    approximately 3.85%
    medium materiality
    Medium
    Fiscal 2027 GAAP and Non-GAAP Income Tax Rate
    approximately 25%
    low materiality
    High

    Operational metrics

    24
    Service revenue
    $122.9Mup 3% YoY
    Q1 FY27

    Record service revenue, supported in part by marketplace activity.

    Custodial revenue
    $174.3Mup 11% YoY
    Q1 FY27

    Record custodial revenue.

    Interchange revenue
    $57.4Mup 5% YoY
    Q1 FY27

    Reflecting higher member spend and transaction activity, though growth was slower than previous periods.

    Gross profit
    $256.3M
    Q1 FY27

    Record gross profit, with margin expansion driven by improved fraud prevention.

    GAAP Net Income
    $69.4M
    Q1 FY27

    Reported GAAP net income for the quarter.

    Non-GAAP Net Income
    $105.1M
    Q1 FY27

    Reported non-GAAP net income for the quarter.

    Adjusted EBITDA
    $164.5Mup 17% YoY
    Q1 FY27

    Adjusted EBITDA margin expanded due to operational efficiencies.

    Cash balance
    $265M
    End of Q1 FY27

    Cash and cash equivalents at the end of the quarter.

    Debt outstanding
    $943M
    End of Q1 FY27

    Total debt outstanding net of issuance costs.

    Share repurchases executed
    $123M
    Q1 FY27

    Amount of outstanding shares repurchased during the quarter.

    Share repurchase authorization increase
    $1B
    Q1 FY27

    Board increased the share repurchase authorization.

    HSA cash contracts maturing
    $3.2B
    FY27

    Remaining HSA cash contracts maturing in fiscal year 2027.

    Forward treasury contracts
    $3.5B
    FY27-FY29

    Contracts effectively lock in 5-year treasury rates to reduce volatility.

    Fraud reimbursements
    $0.3Mdown from $3.2M in Q1 FY26
    Q1 FY27

    Reflecting improved fraud prevention and detection capabilities.

    AI-driven email reduction
    25%
    Q1 FY27

    Improving response times and lowering workload.

    AI-enabled automation manual effort reduction
    >90%
    Q1 FY27

    Leading to significant efficiency gains in targeted workflows.

    AI-enabled self-service contacts reduced
    >50,000
    Q1 FY27

    Contributing to a more scalable operating model.

    Fraud costs decline
    nearly 90%compared with Q1 FY26
    Q1 FY27

    Fraud remained below target, and card acceptance improved.

    Mobile monthly active usage growth
    90%YoY
    Past year

    Significantly expanded digital engagement.

    Marketplace members
    >10,000
    Q1 FY27

    Accessing health-related programs and products.

    Marketplace transactions via mobile app
    >2/3
    Q1 FY27

    Underscoring the long-term digital strategy.

    Metabolic health program economics
    $90-$100
    Per member per month

    The most active program in the marketplace.

    Men's health program economics
    >$50
    Per participating member per month

    New program showing rapid uptake with a longer-term subscription potential.

    HSA qualified plan adoption on exchanges
    30%vs 2% a year ago
    Current

    Significant market expansion driven by Bronze plans.

    Industry KPIs

    4
    MetricValueDetails
    Utilization trendsSlight downshift
    Client retention new winsStrong
    Membership covered lives by line172,000new HSAs
    Adjusted EPS EBITDA leverage guidance$164.5MUSD

    Product announcements

    2
    ProductTypeDetails
    Marketplace Diagnostics and Men's Healthexpansion
    Oura Ring 5launch

    Deals & partnerships

    1
    UnitedHealth (acquiring Allegis)Acquisition (competitor)

    Allegis, a white-labeled software provider, is being acquired by UnitedHealth. HealthEquity views this as a potential net positive, as existing clients of Allegis may view the tie-up as competitive and seek alternatives.

    Risks & headwinds

    4
    Seasonal medical claim usage utilizationQ1 FY27, expected to normalize

    Approximately $2 million impact on service costs in Q1 FY27

    Mitigation: The company has pushed this beat back into the forecast, expecting costs to return to prior actuarial assumptions.

    Slower interchange revenue growthQ1 FY27

    5% YoY growth in Q1 FY27, slower than previous periods

    Mitigation: Reflected some interchange conservatism in the current outlook; monitoring for potential behavior shifts in consumer spending.

    Competitive environment changes from Allegis acquisitionOngoing

    Potential for existing clients of Allegis to view the UnitedHealth tie-up as competitive.

    Mitigation: HealthEquity is watching for these movements, viewing it as a potential opportunity for their direct-to-client model.

    Consumer education for Bronze plansOngoing

    Only 30% of people on exchanges are in HSA qualified plans (up from 2% a year ago), indicating a new muscle for consumers.

    Mitigation: Working through channel partners and brokers to educate consumers on the benefits of HSAs, especially with Bronze plans.

    Q&A highlights

    8

    What is the gating function for investing in sales and marketing to drive marketplace growth?

    There is no gating function for sales and marketing spend in the marketplace, as its growth is driven by member engagement within the mobile experience. The focus is on scaling foundations, expanding visibility, enhancing marketing to existing members, and adding new programs, rather than external marketing spend.

    “There's really no gating function because it's not a channel that's dependent on marketing spend like other e-commerce sites would be.”

    asked by Stanislav Berenshteyn · answered by Scott Cutler

    2 min read6 chapters

    Detailed Narrative

    01

    Strategic Platform Evolution

    HealthEquity is evolving beyond traditional administration to a comprehensive healthcare financial operating system. This platform integrates accounts, assets, payments, investing, marketplace, digital engagement, and advisory capabilities. The strategy aims to expand the value of each member relationship, improve efficiency, and drive durable compounding as accounts mature, reinforcing the company's long-term growth outlook.

    02

    HSA Growth and Member Engagement

    The company outpaced industry HSA account growth in Q1 FY27, with total HSA assets increasing by 19% and new HSAs from sales growing 15%, adding 172,000 new accounts. Member engagement deepened, evidenced by a 90% year-over-year increase in mobile monthly active usage. Over two-thirds of marketplace transactions now occur through the mobile app, contributing to an expanded lifetime value per member.

    03

    AI-Driven Operational Efficiency

    HealthEquity is leveraging technology and AI to enhance the member experience, bolster security, and reduce the cost to serve. AI-driven tools have reduced manual handling of member and client service emails by 25%. In targeted workflows like card servicing and claims inquiries, AI-enabled automation cut manual efforts by over 90% and accelerated processing times by up to 50%, leading to a nearly 90% decline in fraud costs year-over-year.

    04

    Marketplace Expansion and Economics

    The marketplace is emerging as a significant driver of engagement, now serving over 10,000 members with health-related programs and products. Recent expansions include diagnostics and men's health, with metabolic health programs being the most active, generating $90-$100 per member per month. The company prioritizes marketplace additions based on member spending patterns and curates high-value products, with new offerings like Oura Ring 5 and men's health showing rapid uptake.

    05

    Capital Allocation and Share Repurchase

    HealthEquity's Board increased the share repurchase authorization by $1 billion, reflecting strong confidence in the business's long-term outlook and cash generation capabilities. The company remains an active buyer of its shares, having repurchased $123 million in Q1 FY27. This capital allocation strategy maintains flexibility for both share repurchases and potential portfolio acquisitions, without impacting the ability to finance future M&A opportunities.

    06

    Custodial Yield Management

    The company has $3.2 billion of HSA cash contracts maturing in fiscal 2027, weighted towards the back half⚖️ of the year. To mitigate volatility, HealthEquity has forward treasury contracts outstanding on $3.5 billion of maturities across fiscal years 2027 through 2029, effectively locking in 5-year treasury rates at approximately 3.9% net of costs. This program aims to narrow the range of potential outcomes tied to movements in the 5-year treasury benchmark.

    AI-generated summary of the company’s earnings call. Not investment advice.